Author Details

Покатаев, Илья Анатольевич

Issue Section Title File
Vol 18, No 1 (2016) Articles Systemic drug therapy of metastatic pancreatic cancer PDF
(Rus)
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 21, No 3 (2019) Articles Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis
Vol 23, No 2 (2021) CLINICAL ONCOLOGY Pharmacogenetic markers of chemotherapy toxicity in gastrointestinal tumors: a preliminary analysis PDF
(Rus)
Vol 24, No 4 (2022) CLINICAL ONCOLOGY Place of durvalumab in the treatment of biliary tract cancer: A review PDF
(Rus)
Vol 26, No 1 (2024) Articles Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study PDF
(Rus)
Vol 26, No 2 (2024) Articles Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study PDF
(Rus)
Vol 26, No 3 (2024) Articles Comparison of efficacy and safety of regorafenib and anti-EGFR targeted therapy in metastatic colorectal cancer: A retrospective study PDF
(Rus)
Vol 26, No 3 (2024) Articles The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study PDF
(Rus)
Vol 26, No 3 (2024) Articles Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study PDF
(Rus)
Vol 26, No 3 (2024) Articles Role of enzyme replacement therapy for exocrine and nutritional insufficiency in patients with malignancies: A review PDF
(Rus)
Vol 26, No 4 (2024) Articles First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx PDF
(Rus)
Vol 27, No 1 (2025) Articles Efficacy and safety of immunotherapy for metastatic renal cell carcinoma: A retrospective study PDF
(Rus)
Vol 27, No 3 (2025) Articles Safety and toxicity of first-line combination therapy in patients with advanced renal cell carcinoma: A real-world retrospective study PDF
(Rus)
Vol 27, No 3 (2025) Articles Adjuvant targeted therapy in patients with skin melanoma: evidence from Russian real-world clinical practice (RATIONALE study) PDF
(Rus)
Vol 27, No 3 (2025) Articles Real-world efficacy and safety of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: Updated data from a Russian observational study PDF
(Rus)

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).